✦ LIBER ✦

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

✍ Scribed by Noboru Konishi; Takayuki Enomoto; Gregory Buzard; Masato Ohshima; Jerrold M. Ward; Jerry M. Rice

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 761 KB
Volume: 69
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19920501)69:9<2293::aid-cncr2820690915>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of ras oncogene p21 protein i

Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma

✍ Alberto Ruol; Janet K. Stephens; Fabrizio Michelassi; Andrea Segalin; Silvia Chi 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

## Abstract In order to investigate the value of ras oncogene expression as a prognostic indicator in esophageal squamous cell carcinoma, we evaluated the level of ras oncogene protein product (p21) in 52 specimens resected between 1977 and 1986. All patients were followed until death or for at lea

Expression of ras oncogene p21 protein i

Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia

✍ Bogdan Czerniak; Fritz Herz; Wojciech Gorczyca; Leopold G. Koss 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 957 KB

Comparison of K-ras point mutations at c

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients

✍ Mao-Min Song; Yoshinori Nio; Ming Dong; Katsuhiro Tamura; Kohsuke Furuse; Yu-Lin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

p21Ras downstream effectors are increase

p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between Ras-mutated and Ras-wild-type lesions

✍ Arno Kalkuhl; Jacob Troppmair; Albrecht Buchmann; Stefan Stinchcombe; Christoph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Mouse liver tumors frequently harbor activating ras gene mutations. Downstream effector molecules of p21 Ras include Raf-1 kinase which mediates external signals via kinase signaling pathways to nuclear transcription factors including c-Fos and c-Jun. Mouse liver tumors with differing ras-mutational

Immunohistochemical detection of metallo

Immunohistochemical detection of metallothionein expression and its correlation with ras activation in melanoma

✍ Dr. V. K. Shukla; P. Laidler; K. Horgan; L. E. Hughes; R. A. Padua; B. Jasani 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Pyrimido-pyrimidine modulation of EGF gr

Pyrimido-pyrimidine modulation of EGF growth-promoting activity and p21ras expression in rat mammary adenocarcinoma cells

✍ Rosemarie B. Lichtner; Gary E. Gallick; Garth L. Nicolson 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

RA 233, a pyrimido-pyrimidine analogue developed originally as an antiplatelet agent, has reduced the incidence of tumor metastases in clinical trials. However, in animal tumor models antimetastatic therapy using RA 233 has been inconsistent. We therefore tested RA 233 for additional effects, such a